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Abstract
Objective: The aim of the study was to analyze immediate results, rate of complications and re-interventions during medium-term outcome in
pediatric patients with native or recurrent aortic coarctation. We focused on an age-related therapeutic approach comparing surgical and trans-
catheter treatment.Methods: This is a retrospective, single-centre, clinical observational trial including 91 consecutive patients (age: 1 day—18
years) treated for native coarctation in 67 and recurrent aortic coarctation in 24 patients. Surgical treatmentwas performed in 56, trans-catheter
treatment with balloon dilatation in 17, and by stent implantation in 18 patients. According to the age groups, we treated 48 children in group A
(<6months of age), 16 in group B (6months—6 years), and 27 in group C (>6 years). A total of 41 patients in group Awere operated (85%), patients
in group B received either surgical or trans-catheter treatment (50% vs 50%), and 16 patients in group C were treated by stent implantation (62%).
Results: Immediate results were excellent with a significant release of pressure gradient in all three age groups (64.7% in group A, 69.1% in group
B, and 63.3% in group C). Complication rate and re-intervention rate (surgical and interventional) were both comparable between the three age
groups (complications: group A 8.3%, group B 6.3%, and group C 3.7%; re-interventions: group A 16.6%, group B 18.8%, and group C 18.5%). Midterm
outcome after a median follow-up period of 17.5 months was satisfactory with a re-intervention-free survival after 17.5 months of 83.4%, 81.2%,
and 81.5% in group A, group B, and group C, respectively. Conclusions: The current strategy of an age-related therapy for native and recurrent
aortic coarctation in our institution is surgery in infants <6 months (group A), either surgery or balloon dilatation in younger patients <6 years
(group B), while in older children >6 years of age (group C) the trans-catheter treatment with stent implantation is an excellent alternative to
surgery. Balloon dilatations showed limited results with an overall re-intervention rate of 53% and, therefore, should mainly be performed as a
rescue procedure or in recurrent aortic coarctation in neonates.
# 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Aortic coarctation (CoA) is a common congenital lesion
in children with a frequency of 4—6% of all types of
congenital heart defects. Aortic obstruction may be
relieved by cardiac surgery or by trans-catheter techni-
ques. Trans-catheter techniques include balloon angio-
plasty and endoluminal stent implantation, which have
been established with successful immediate and long-term
results in the past [1—7]. However, different clinical* Corresponding author. Address: Pediatric Cardiology, University Children’s
Hospital, Steinwiesstrasse 75, CH - 8032 Zurich, Switzerland.
Tel.: +41 44 266 7617; fax: +41 44 266 7981.
E-mail address: walter.knirsch@kispi.uzh.ch (W. Knirsch).
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1010-7940/$ — see front matter # 2010 European Association for Cardio-Thoracic S
doi:10.1016/j.ejcts.2010.09.048studies comparing these three therapeutic options show
conflicting data [8—14]. The long-term results of CoA, for
either native or recurrent CoA after surgery, have been
described for adolescents and adults [15,16], but the
influence of the factor age, especially in the younger
pediatric population, on the outcome of treatment of CoA,
has not been described.
In our institution, neonates and infants with native CoA
are routinely treated by surgery. By contrast, older children
and adolescents are treated by stent implantation for native
CoA. Balloon dilatation is performed mainly in recurrent
aortic coarctation (Re-CoA), especially in neonates and
infants.
Therefore, the aim of our study was to evaluate our age-
related approach by comparing the results of the three
treatment strategies: surgery, balloon dilatation, and stent
implantation.urgery. Published by Elsevier B.V. All rights reserved.
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2.1. Patients
In our institution, all consecutive patients treated for
native CoA and Re-CoA between September 2001 and
September 2006 with an age younger than or equal to 18
years were treated according to our age-related treatment
using surgery by a majority for neonates and infants, and
stent implantation for older children (>6 years) and
adolescents for native and recurrent CoA. The study was
designed as a single-center, clinical, retrospective, observa-
tional trial. Medical records, angiographies, and echocardio-
graphic and hemodynamic data were reviewed. Further
follow-up was obtained by clinical evaluation (blood pressure
gradient between upper and lower extremities) and two-
dimensional and Doppler echocardiography. Study end points
were re-interventions either by a second catheter interven-
tion or by surgery. The study was approved by the local ethics
committee.
All patients included in the study cohort had the cardiac
diagnosis of an isolated native CoA or Re-CoA, either after
surgery or after catheter-based therapy. Concomitant minor
cardiac anomalies, for example, small ventricular septal
defect (VSD), atrial septal defect (ASD), or mild aortic valve
stenosis (AS, systolic blood pressure gradient  20 mmHg)
were included, while all children with other major cardiac
anomalies, for example, accessory severe generalized
hypoplastic aortic arch anomalies such as in patients with
hypoplastic left heart syndrome, were excluded.
The indications for treatment of native CoA with respect
to Re-CoA were similar with (1) systolic blood pressure
gradient of more than 20 mmHg between arms and legs, (2)
an arterial hypertension of the upper extremities at rest or
during exercise (after exclusion of other reasons for arterial
hypertension), and (3) signs of left ventricular hypertrophy in
echocardiography.
To compare the age-related therapy for native CoA and
Re-CoA, we arbitrarily divided our patient cohort into three
groups according to their age with group A less than 6 months
of age, group B between 6 months and 6 years of age, and
group C between 6 and 18 years of age.
2.2. Cardiac surgery
Cardiac surgery was performed by two experienced
surgeons. The coarctation site was approached through a
muscle-sparing left posterior thoracotomy with an extra- or
transpleural access or by median sternotomy. The technique
of extrapleural access to the operation site was performed as
described earlier by Dave et al. [17]. Full dissection and
mobilization of the aortic arch and the arch vessels and
mobilization of the descending aorta permitted an extended
resection and end-to-end anastomosis [18,19] of the
descending aorta to the distal aortic arch without tension.
2.3. Catheter interventions
Cardiac catheter interventions were performed under
general anesthesia. Percutaneous vessel access was achieved
in all cases via the femoral artery. Heparin (100 units kg1)was given after successful arterial access, and repeated after
1 h (50 units kg1). The coarctation was crossed in a retro-
grade manner with a diagnostic catheter, and peak pressure
gradients between the ascending aorta and the descending
aorta were measured. Angiography of the coarctation was
performed and recorded in the left anterior oblique (LAO 10—
208) and lateral projections (LAO 908). The following bilateral
measurements were performed: smallest diameter of the
coarctation; diameter of the transverse aortic arch; and
diameter of the descending aorta proximally and distally to
the site of coarctation. The diameter of the balloon used for
dilatation was chosen equally or 1 mm more than the
diameter of the transverse aortic arch. Dilatation was
performed over a period of 10 s; adenosine was used in
some cases. Stent implantation was performed via a retro-
grade approach using a long sheath, which allowed a proper
stent positioning and hand injections of contrast medium
during implantation [20]. The stent was placed in most of the
cases on a BiB balloon (balloon in balloon, NuMed Inc.,
Nicholville, NY, USA) allowing a precise and safe stent
delivery. Immediately after balloon dilation or stent
implantation, the invasive residual pressure gradient was
measured and angiography was performed.
2.4. Follow-up
At the time of early (24 h after intervention) and late (last
follow-up) follow-up, Doppler echocardiographic gradients
weremeasured in both the surgical and trans-catheter group,
respectively.
Significant early and late complications of the procedures
were chylothorax, aortic aneurysm, vessel thrombosis, and
stent dislocation.
Re-intervention was defined as secondary surgical or
catheter interventional redo. Hemodynamic indication for
re-intervention was a systolic pressure gradient of more than
20 mmHg across the recoarctation of the aortic arch. The
follow-up period ended with the need for a re-intervention.
2.5. Statistics
Results are presented as mean and standard deviations or
as median and ranges, as appropriate. For comparisons of
Doppler gradients before and at day 1 after intervention, we
used the Wilcoxon signed-rank test for each age group. For
comparison of Doppler gradients before and at day 1 after
intervention and for comparison of the performed procedure
(surgery, balloon dilatation, or stent implantation), we used
the Mann—Whitney U test to compare two procedures; and
the Kruskal—Wallis one-way analysis of variance was used to
compare all three procedures. Analyses were performed
using Statistical Package for Social Sciences (SPSS) 16 (SPSS
Inc., Chicago, IL, USA). A p value less than 0.05 was
considered as significant.
3. Results
We enrolled 91 patients (61males) treated for CoA (n = 67)
and Re-CoA (n = 24). The median age at the time of the
intervention was 0.4 years (range 1 day—18 years). The
patients were treated either by surgery (n = 56) or by
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were treated at an age <6 months (group A), 17 children
were treated at an age between 6 months and 6 years (group
B), and 26 older children and adolescents were treated at an
age >6 years (group C). The age distribution of children
treated for CoA and Re-CoA with the different techniques is
shown in Figs. 1 and 2.
The follow-up period for the whole patient group was 17.5
months (range 1 day—60months), within group A 20.5months
(1 day—60 months), group B 15 months (2—33 months), and
group C 13 months (0.5—57 months).
Five patients younger than 6 months of age (group A) with
native CoAwere treated by balloon dilatation (n = 4) or stent
implantation (n = 1) instead of surgery in a rescue procedure
due to severe congestive heart failure. Four of five patients
were treated by surgery after recovery of myocardial
function; one patient after balloon dilatation recovered
completely without any further re-intervention (Fig. 1).
One 7-year-old patient (group C) with native CoA was
treated by surgery instead of stent implantation because
moderate transverse aortic-arch hypoplasia was associated
with CoA.
3.1. Cardiac surgery
Within the 91 enrolled children, 56 (37 males) underwent
cardiac surgery. The median age of this group was 1.7 years
(range 1 day—18 years) and median weight 4.8 kg (1—60 kg).
The surgical access was left-sided posterior thoracotomy in
52 and median sternotomy in four patients, in one due to
simultaneous ASD and VSD closure, and in three patients due
to aortic arch extension plasty (all patients with Re-CoA). The
surgical technique was an extended end-to-end anastomosis
in 51 patients (91%), subclavian flap plasty in one (1.8%), U-[()TD$FIG]Fig. 1. Age-related treatment of native aortic coarctation (CoA)sliding plasty in one (1.8%), and patch augmentation in three
(3.6%).
3.2. Catheter interventions
Trans-catheter interventions were balloon angioplasty
performed in 17, and stent implantation in 18 patients (total
35 patients). The median age was 13.4 years (range 17 days—
17 years) and median weight 28 kg (3.2—6 kg). Twenty-two
patients had native CoA (61%) and 13 had Re-CoA.
Children<6 years of age treated by catheter interventions
mainly underwent balloon angioplasty (13 of 15, 87%),
whereas in the group of children >6 years of age (group C)
stent implantation predominated (16 of 20, 80%), as shown in
Figs. 1 and 2.
The median diameter of the used balloons was 8 mm
(range 5—14 mm). These balloons had a low-pressure profile
with a maximum pressure of 3.5 atm) to be achieved during
dilatation. The following stents were used: Cheatham
Platinum (CP) Stents (NuMed Inc., Nicholville, NY, USA) in
nine patients, Palmaz Genesis Stents (Johnson & Johnson
Interventional System, Somerville, NJ, USA) in seven
patients, and Jomed Stent (JOMED Deutschland, Haan,
Germany) in two patients.
A significant decrease of Doppler gradient (%) was
achieved in all three age groups (64.7% in group A, 69.1%
in group B, and 63.3% in group C, p < 0.05), respectively
(Table 1, Fig. 3). Comparing the type of procedure (surgery,
balloon dilatation, or stent implantation), we found in group
A significant higher decrease of Doppler gradient in patients
treated by surgery (70.2%) compared with balloon dilatation
(34.4%) (36.6  17.3 pre- vs 10.9  15.0 mmHg post-day 1
after surgery compared with 48.0  7.3 pre- vs
31.5  18.6 mmHg post-day 1 after balloon dilatation,by cardiac surgery, balloon dilation and stent implantation.
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Fig. 2. Age-related treatment of recurrent aortic coarctation (Re-CoA) by cardiac surgery, balloon dilation and stent implantation.p = 0.017). No differences between the three types of
procedures were found in group B. In group C, we found a
significant higher decrease of Doppler gradient in patients
treated by stent implantation (73.7%) compared with balloon
dilatation (10.3%) (43.3  15.5 pre- vs 11.4  13.0 mmHg
post-day 1 after stent implantation compared with
39.8  16.3 pre- vs 35.7  11.2 mmHg post-day 1 after
balloon dilatation, p = 0.022).
According to the type of pathology of CoA (native or
recurrent), significant decrease in Doppler gradients for
native versus Re-CoA were: in age group A 65.0% versus
62.5%, in age group B 68.7% versus 71.6%, and in age group C
48.7% versus 69.8%. Comparing the type of CoA (native or
recurrent), we found no differences in decrease of Doppler
gradients within each group.
In the whole patient group, re-interventions became
necessary in 16 patients (17.6%), including eight patients in
group A (children<6months) (16.6%), three patients in group
B (children between 6 months and 6 years) (18.8%), and five
patients in group C (children >6 years) (18.5%). Re-
interventions were performed after a median time intervalTable 1. Immediate hemodynamic results by Doppler echocardiography, rate of comp
groups for pediatric patients with native and recurrent coarctation of aortic arch.
Group A Group
Age < 6 months
(n = 48)
Age > 6
(n = 16
Doppler gradient pre [mmHg] 37.7  16.9 46.0 
Doppler gradient post-day 1
[mmHg]
13.3  16.3* 14.2 
Rate of gradient reduction [%] 64.7 69.1
Rate of complications [n] 4 (8.3%) 1 (6.3
Rate of re-interventions [n] 8 (16.6%) 3 (18.
Follow-up, median (range)
[months]
20.5 (0—60) 15 (2—
Data are given as mean and standard deviation. Wilcoxon signed-rank test was used
* p < 0.05.of 3 months (range 1 day—50 months) of the primary
intervention.
Twelve re-interventions were necessary in patients
treated for native CoA (18%) and three redos in patients
with Re-CoA (12.5%) (Figs. 1 and 2).
In all other patients, after a median follow-up of 17.5
months, there was no significant increase of Doppler
gradients.
Early and late complication rates for the whole patient
group were low (6.6%).
Complications occurred in four patients of group A
(children <6 months of age) (8.3%). After surgery, chy-
lothorax requiring tube drainage occurred in one patient.
After percutaneous intervention, stent dislocation into the
descending aorta occurred in one patient. In this patient, a
balloon dilatation of the coarctation and placement of the
dislocated stent in the descending aorta was possible and a
secondary re-operation could be successfully performed
after 2 months. Arterial thrombosis occurred in another two
patients after trans-catheter intervention. In group B
(children between 6 months and 6 years of age), there waslications and re-interventions during medium-term follow-up in different age
B Group C Total
months—6 years
)
Age > 6 years
(n = 27)
Age 0—18 years
(n = 91)
13.5 45.5  16.3 41.4  16.4
15.6 * 16.7  14.9 * 14.4  15.7 *
63.3 65.2
%) 1 (3.7%) 6 (6.6%)
8%) 5 (18.5%) 16 (17.6%)
33) 13 (0.5—57) 17.5 (0—60)
for comparison of Doppler gradient pre versus post-day 1.
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Table 2. Review of the literature for trans-catheter and surgical therapy for native and recurrent coarctation of the aortic arch in different age groups [2,3,5—
11,19,25].
Author/
year
CoA/
Re-CoA
Type of
treatment
Number of
patients
(n)
Age
range
Complications Re-
interventions
Median
follow-up
(months)
Aneurysm Thrombosis Stent disl Chylothorax Death Others
Wood et al.
(2004) [19]
CoA Surgery 181 0—1 years 0.5%zz 2.7% 2% 90
Wright et al.
(2005) [25]
CoA Surgery 83 0—1 years 2% 4% 3%yy 6% 54
Ovaert et al.
(2000) [6]
CoA Balloon 69 6 months—
16.8 years
1% 11% 1% 13% 34
Hamdan et al.
(2001) [2]
CoA/
Re-CoA
Stenting 34 4—36 years 11% 4% 9%* 9% 28
Harrison et al.
(2001) [3]
CoA/
Re-CoA
Stenting 27 14—63
years
9% 3% 6%y 4% 22
Marshall et al.
(2000) [5]
CoA/
Re-CoA
Stenting 33 5—60
years
3% 6%z 24% 27
Suarez de Lezo
et al.
(2005) [7]
CoA/
Re-CoA
Stenting 73 20  12
years
7% 3% 1% 0% 60
Hernandez-
Gonzalez
et al.
(2003) [9]
CoA/
Re-CoA
Surgery 28 7  4.1
years
25% 4% 7% 36%§ 21% 16
CoA/
Re-CoA
Balloon 30 6.6  4.4
years
17% 10% 3.5% 33%jj 50% 16
Cowley et al.
(2005) [8]
CoA Surgery 16 5.7  2.1
years
0% 13% 136
CoA Balloon 20 6.3  2.0
years
35% 30% 127
Pedra et al.
(2005) [10]
CoA Balloon 15 18  10
years
13% 7% 60
CoA Stenting 21 24  11
years
5% 5% 10% 10% 22
Rodes-Cabeau
et al.
(2007) [11]
CoA Surgery 30 1—35 years 3% 60%** 0% 43
CoA Balloon 31 1—38 years 1% 16% 26% 38
CoA Stenting 19 1—38 years 11% 5% 38
Abbreviations: CoA: coarctation of aortic arch, disl: dislocation, Re-CoA: recurrent coarctation of aortic arch; *: 1 femoral arteriovenous fistula, 1 retroperitoneal
hematoma, 1 dislocation of ruptured balloon fragment into the left axillary artery with need for surgical repair; y: 1 balloon rupture, 1 cerebral insult; z: 1 myocardial
infarction, 1 complete heart block with need for cardiopulmonary resuscitation for 30 s; §: 2 major bleedings, 1 systemic arterial hypertension crisis, 1 diaphragmatic
nerve injury, 3 pulmonary sepsis, 1 cardiogenic shock, 2 dehiscence sutures; jj: 3 major bleedings, 1 systemic arterial hypertension crisis, 1 anaphylactic shock, 1
cardiogenic shock, 4 inguinal hematoma; : 3 access site complications, 2 paradoxical arterial hypertension, 1 hematuria, 1 chest hematoma; **: 2 pleural effusion, 1
respiratory distress, 3 access site complications, 11 paradoxical hypertension, 1 reperfusion syndrome; yy: 3 technical related complications; zz: 0.5% hospital/30-day-
mortality, plus 15 (8%) late deaths.one significant complication (6.3%) with the occurrence of a
significant aortic aneurysm after balloon dilatation leading to
re-operation after 7 months. In group C (children >6 years of
age), arterial thrombosis of the femoral artery occurred in
one patient (3.7%) treated surgically for Re-CoA with
peripheral cannulation for extracorporeal perfusion; a vein
graft was used as bypass material.
There was no mortality associated with surgery or trans-
catheter treatment or redo intervention.
4. Discussion
This is the first systematic report presenting an age-
related comparison of the therapy of native or recurrent
aortic coarctation from infancy to adolescence.
The strategy in our center is primary surgery in infants less
than 6 months of age and primary trans-catheter treatment
with stent implantation in children >6 years of age. Patientsbetween 6 months and 6 years of age receive either surgery or
balloon dilatation,mainly depending on themorphology of the
coarctation. Therefore, the indication for surgery instead of
balloon dilatation or stent implantation is given in case of
associated severe aortic arch hypoplasia. The extent of aortic
arch hypoplasia is variable and requires interdisciplinary
decision-making procedures by surgeons and interventionists.
This age-related approach has proven to be practicable
with promising early and late results. Primary treatment at
any age, either by surgery or by trans-catheter treatment,
leads to a significant and lasting reduction of the pressure
gradient across the aortic arch. We have seen an acceptable
low complication rate between 3.7% in group C (>6 years),
6.3% in group B (6 months—6 years) and 8.3% in group A (<6
months). A re-intervention rate between 16.6 and 18.8% is
also comparable with the results reported of other study
groups, although the hemodynamic indication for re-inter-
vention in our institution is rather restrictive [7,8,10]. The
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Fig. 3. Decrease of echocardiographic Doppler gradient comparing mean value
pre and posterinterventional at day 1 in children treated for CoA, and Re-CoA in
three age groups with 64.7% in group A (age < 6months), 69.1% in group B (age 6
months to6 years), and63.3% ingroupC (age > 6 years). Forall groups:p < 0.05.different re-intervention rates for balloon dilatation,
surgery, and stent implantation are shown in Table 2.
In the very young patients <6 months of age (group A), the
early and long-term results of surgical resection are excellent.
These data confirm surgery as the treatment of choice in this
specific age group. Wood et al. have shown excellent long-
term results after extended arch aortoplasty confirming our
data [19]. A limited number of studies comparing surgery and
balloon dilatation showed significantly lower re-intervention
and complication rates after surgery than after balloon
angioplasty [7,8,10]. In our institution, percutaneous proce-
dures in this age group mainly serve as a rescue therapy for
patients in severe heart failure, to stabilize their clinical
condition and bridge them to definitive surgical correction
later on. We were able to perform either balloon angioplasty
(n = 4) or stent implantation (n = 1) in these high-risk patients
with a good initial relief of the pressure gradient without
significant morbidity or mortality (Fig. 1).
In children between 6 months and 6 years of age (group B)
with isolated CoA, the acute results of reduction of gradients
between surgery and angioplasty are comparable, as shown
in the literature for similar age groups [6,21]. In our series,
the rate of re-interventions in this age group was higher after
angioplasty (37.5%) (Fig. 1). Re-intervention after angio-
plasty was necessary in three patients (Fig. 1): in one due to
the formation of an aortic aneurysm after 7 months needing
corrective surgery, and in two patients due to early (after 2
months) or late (after 16 months) restenosis leading to
surgical repair. The overall rate of significant aortic aneurysm
formation leading to surgery in our group was very low (1.1%).
Nevertheless, long-term follow-up using magnetic resonance
imaging (MRI) is recommended to detect aneurysm formation
even years after primary or secondary intervention [8]. Stent
implantation is not recommended in this age group due to the
need for frequent redilatation in growing children, the lack
of redilatable stents until adulthood, a high incidence of
intimal proliferation in small stents and the potential
development of post-stent aneurysm formation [20].
In children>6 years of age (group C), stent implantation is
an excellent therapeutic alternative to surgery. Stents have
the unique property to avoid elastic recoil of the vessel wall
and to fix and stabilize the dissected intima and, by this,
minimize the risk for aortic rupture and aneurysm formation.
Previous studies have shown the safety of stent implantations
in adolescents with excellent medium-term outcomes
[2,3,10,22,23]. In our series, stent implantation was
performed successfully with a low rate of re-interventions
(6.3%) and no complications [2,4,11]. This interventional
approach is suitable either for native CoA (Fig. 1) as well as
for Re-CoA (Fig. 2) and the results are comparable to those of
surgery. Of course, due to somatic growth of the children,
there exists the need for further redilatation after stent
implantation. We now routinely implant the CP stent (NuMed
Inc., Nicholville, NY, USA), which enables redilatation
sufficient for adult aortic sizes [18]. This platinum stent
has perfect material properties with high radial forces,
excellent tissue tolerance with optimal adhesion to the
vessel wall, low fracture rates during follow-up, acceptable
stent shortening during redilatation, and MRI compatibility
[18,21]. It has been shown that serial dilatations of the CP
stent, either covered or uncovered, are feasible, safe, andeffective [21]. The only ‘re-intervention’ (balloon redilata-
tion) in our study group was necessary due to outgrowth of
the original stent diameter in one patient.
We prefer to implant covered stents in patients with
subatretic CoA, in adult patients, or after aortic dissection. In
our opinion, in patients with a complex CoA/Re-CoA with
hypoplasia of the aortic arch, surgery is, in most cases, a safe
and the more effective approach.
Limitations of this study are its retrospective and non-
randomized design, the miscellaneous collective, the
relatively low number of patients in the subgroups, and
only medium-term follow-up time. Isolated CoA may be
associated with borderline hypoplasia of parts of the
transverse aortic arch. Therefore, we included these
borderline patients. Other confounders such as experience
of the surgeon and anatomic differences could not be
completely ruled out.
Promising new devices such as the growth stent or
biodegradable stents have been developed [24]. Possibly,
they might help to shift successful and durable trans-catheter
interventions in early childhood and, by this, replace a certain
amount of surgical procedures in these patients.
In the future, further prospective, multicenter trials are
needed to investigate the medium- and long-term outcome
of surgical and trans-catheter treatment by comparing
patients in different age groups ranging from the neonatal
period until adolescence and young adulthood.
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